Skip to main content

Advertisement

Table 1 Characteristics of the study population before surgery

From: Implementation of goal-directed fluid therapy during hip revision arthroplasty: a matched cohort study

  Control group (n = 130) GDFT group (n = 130) p
Age (years) 72 (60–76) 71 (62–75) 0.643
Sex (w/m) 86/44 81/49 0.440
Body height (cm) 166 (160–171) 168 (163–175) 0.155
Body weight (kg) 76 (65–85) 79 (64–90) 0.177
BMI kg/m2 27.36 (24.69–30.06) 27.77 (23.80–32.11) 0.658
CCS 3 (2–5) 3 (2–4) 0.249
ASA score 2 (2–3) 2 (2–3) 0.730
P-POSSUM score 27.00 (23.00–31.00) 29.00 (24.00–33.00) 0.102
  1. Parameters are shown as median and (25th percentile–75th percentile). CCS: The Charlson Comorbidity Score includes age, previous myocardial infarction or congestive heart failure, peripheral vascular disease, cerebrovascular disease, existing dementia, COPD, connective tissue disease, peptic ulcer disease, diabetes mellitus, moderate to severe chronic kidney disease, hemiplegia, leukaemia, malignant lymphoma, solid tumour, liver disease, and AIDS. Different points were distributed for the pre-existing diseases, and so, the survival rate during the first 2 years can be calculated